News Posts List
A case-control study of occupation and kidney cancer risk
08/12/2012
The role of occupation in the etiology of renal cell carcinoma (RCC) is unclear. Here, we investigated associations between employment in specific occupations and industries and RCC, and its most common histologic subtype, clear cell RCC (ccRCC).
Kidney Cancer Patients Live Longer With New Vaccine
08/11/2012
immatics Announces Publication of IMA901 Cancer Vaccine Data in Nature Medicine: Immune Response Associates With Longer Survival
Kidney-sparing Surgery Improves Survival in Study
08/11/2012
Researchers at the University of Michigan Comprehensive Cancer Center have found that patients with early stage kidney cancer lived longer when only part of their kidney was removed,
Mixed Results for Avastin Cancer Combos
08/11/2012
Pfizer of New York City released disappointing results of a trial in advanced renal cell carcinoma
Sunitinib in metastatic renal cell carcinoma patients with brain mets
08/11/2012
In patients with brain metastases from RCC, the safety profile of sunitinib was comparable to that in the general metastatic RCC population.
Which antioxidants raise the risk of cancer?
08/10/2012
The Consumer Reports magazine issue of September 2012 notes on page 22 that "far from reducing cancer risk, as a lot of people believe, high doses of some antioxidant supplements may actually increase it, evidence suggests."
Killing cancer: stories from the cutting edge of science
08/10/2012
Tumour-treating electrical fields, a Victorian gout remedy, and an anti-cancer 'virusâ. Meet the scientists tackling our most feared disease in some truly innovative ways
High Dose Intermittent Sorafenib Shows Improved Efficacy
08/10/2012
In an effort to increase efficacy, we studied the effects of increased sorafenib dose and intermittent scheduling in a murine RCC xenograft model.
Difficulty in predicting survival in metastatic renal cancer
08/07/2012
However, survival is now roughly double what was seen before targeted therapy.
Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy
08/07/2012
Hyponatremia is reported to be associated with poor survival in localized renal cell carcinoma and metastatic renal cell carcinoma treated with immunotherapy.
News Feed